Telemedicine: (585) 275-7430
Dr. Kevin Biglan is a Professor of Neurology and the Associate Chair for Clinical Research in the Department of Neurology and the Center for Human Experimental Therapeutics at the University of Rochester School of Medicine and Dentistry in Rochester, New York. He also serves as Director of the National Parkinson Foundation Center of Excellence and Director of the Huntington Disease Society of America Center of Excellence at the University of Rochester. He is fellowship trained in movement disorders and provides comprehensive services to individuals with Parkinson's disease, Huntington's disease, tremor, dystonia and other movement disorders. He also provides botulinum toxin injections for the treatment of dystonia and related conditions.
Dr. Biglan has been actively involved in the development of telemedicine for the provision of care in patients with Parkinson disease and for identifying disease modifying therapy in Parkinson's disease and Huntington's disease. He has been at the forefront of establishing the feasibility of telemedicine in Parkinson disease and Huntington disease, the expansion of its use for clinical care, and the validation of clinical trial outcomes assessed via telemedicine. He conducts weekly movement disorders clinics via telemedicine at various spoke sites throughout New York.